Truemeds, a fast-growing healthtech startup from Mumbai, has successfully raised $85 million (₹740 crore) in its Series C funding round. The investment came from some of the biggest names in venture capital, including Accel, Peak XV Partners, WestBridge Capital, and Info Edge Ventures. This marks a major milestone for the company as it continues to expand its footprint across India’s healthcare market.
The funding was secured in two separate tranches. In the first phase, Accel led with a $44 million investment, followed by the second tranche led by Peak XV Partners. Other investors like WestBridge Capital and Info Edge Ventures also participated, showing strong confidence in Truemeds’ growth potential.
Truemeds plans to use this fresh capital to strengthen its presence in non-metro cities across India. The company will set up new fulfillment centers, launch advanced product lines, and develop a cutting-edge technology hub in Bengaluru. This move is expected to boost operational efficiency, speed up deliveries, and provide better healthcare access to smaller towns and rural areas.
A big part of the investment will go towards building strong engineering capabilities. Truemeds aims to create innovative technology solutions that make medicines more affordable and accessible. With India’s healthtech sector growing rapidly, this step will help the company reach millions of new customers and improve healthcare delivery in underserved regions.
With this funding, Truemeds is set to become a major player in India’s healthtech revolution. As the demand for online healthcare solutions continues to rise, the company’s focus on affordability, technology, and customer trust positions it strongly for the future.
